Cargando…
Follow-up of COVID-19 Vaccine–related Axillary Lymphadenopathy before 12 Weeks Is Unnecessary
Autores principales: | Moy, Linda, Kim, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radiological Society of North America
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096715/ https://www.ncbi.nlm.nih.gov/pubmed/35471114 http://dx.doi.org/10.1148/radiol.220962 |
Ejemplares similares
-
Axillary lymphadenopathy following bivalent COVID-19 booster vaccination
por: Lane, Elizabeth G., et al.
Publicado: (2023) -
COVID-19 Vaccination and Subclinical Axillary Lymphadenopathy on Mammogram: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Axillary Lymphadenopathy After mRNA COVID-19 Vaccination
por: Ahn, Richard W., et al.
Publicado: (2021) -
Axillary Lymphadenopathy Associated With COVID-19 Vaccination: Updates and Recommendations
por: Schwaner, Sandra L.
Publicado: (2022) -
US Evaluation of Axillary Lymphadenopathy Following COVID-19 Vaccination: A Prospective Longitudinal Study
por: Ha, Su Min, et al.
Publicado: (2022)